Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression

To investigate the association between pre-trial expectancy, suggestibility, and response to treatment in a trial of escitalopram and investigational drug, COMP360, psilocybin, in the treatment of major depressive disorder (ClinicalTrials.gov registration: NCT03429075). We used data ( = 55) from our...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Psychological medicine 2024-06, Vol.54 (8), p.1717-1724
Hauptverfasser:	Szigeti, Balázs, Weiss, Brandon, Rosas, Fernando E, Erritzoe, David, Nutt, David, Carhart-Harris, Robin
Format:	Artikel
Sprache:	eng
Schlagworte:	Absorption Adult Anticipation, Psychological - drug effects Citalopram Citalopram - administration & dosage Citalopram - pharmacology Citalopram - therapeutic use Depressive Disorder, Major - drug therapy Depressive personality disorders Double-Blind Method Drug dosages Efficacy Escitalopram - pharmacology Expectancy Female Hallucinogens - administration & dosage Hallucinogens - pharmacology Humans Linear analysis LSD Lysergic acid diethylamide Male Mental depression Mental disorders Mental health Middle Aged Patients Psilocybin Psilocybin - administration & dosage Psilocybin - pharmacology Psilocybin - therapeutic use Psychedelic drugs Suggestibility Suggestion Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!